János Éles

USPTO Granted Patents = 11 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

Richter Gedeon Vegyeszeti Gyar Rt

Years Active: 1980-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473293 - Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives (2025-11-18),

2. 12194050 - Thiadiazine derivatives (2025-01-14),

3. 11026946 - Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives (2021-06-08),

4. 10960007 - Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives (2021-03-30),

5. 10329296 - Indole derivatives (2019-06-25),

6. 8178665 - Process for the production of ezetimibe and intermediates used in this process (2012-05-15),

7. 8034827 - Phenanthridine derivatives as bradykinin antagonists (2011-10-11),

8. 4279916 - Method of treatment using new leurosine derivatives (1981-07-21),

9. 4279915 - Method of treatment using new leurosine derivatives (1981-07-21),

10. 4279816 - N-Formyl leurosine derivatives in a dosage form effective for treating (1981-07-21),

11. 4189432 - N-formyl and N-desmethyl leurosine derivatives (1980-02-19),

Title: János Éles: Innovator in Pharmaceutical Chemistry

Introduction

János Éles is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, János Éles has developed thiadiazine derivatives, which are related to pharmaceutically acceptable salts and biologically active metabolites. These compounds are designed to modulate α7 nicotinic acetylcholine receptor activity in mammalian subjects. Another notable invention is the pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives. These compounds serve as GABAB receptor positive allosteric modulators and are intended for use in treating diseases mediated by the GABAB receptor mechanism.

Career Highlights

János Éles is currently associated with Richter Gedeon Nyrt., a leading pharmaceutical company in Hungary. His work at the company has been instrumental in advancing research and development in the field of medicinal chemistry.

Collaborations

He has collaborated with notable colleagues, including István Borza and Viktor Román, contributing to various projects and innovations in pharmaceutical research.

Conclusion

János Éles continues to be a key figure in pharmaceutical innovation, with his patents reflecting a commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.